Logo 1.png
Aeterna Zentaris Secures New European Patent Related to Use of Macimorelin for the Diagnosis of Growth Hormone Deficiency in Adults
April 19, 2022 08:05 ET | Aeterna Zentaris Inc
– Strengthens intellectual property portfolio for macimorelin and the commercial product Ghryvelin® / Macrilen™ in Europe as the Company plans to pursue even greater protection TORONTO, ONTARIO,...
Adhera Receives European Patent Covering MLR-1019 and Derivatives for Treating Dyskinesias
October 04, 2021 09:15 ET | Adhera Therapeutics, Inc.
Baton Rouge, LA, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Adhera Therapeutics, Inc. (OTCPK: ATRX) ("Adhera" or the "Company"), a clinical stage biopharmaceutical company, is pleased to announce that a new...
CGE Energy Granted Sixth Patent for Innovative Wind Turbine
November 24, 2020 07:30 ET | CGE ENERGY, INC.
BRIGHTON, Mich, Nov. 24, 2020 (GLOBE NEWSWIRE) -- CGE Energy, Inc. (OTCPink: CGEI) is pleased to announce that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No....
IMC Logo.jpg
Immuron Announces it has Received a European Patent Grant for NASH treatment
July 24, 2018 06:30 ET | Immuron Limited
MELBOURNE, Australia, July 24, 2018 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (NASDAQ:IMRN) is an Australian microbiome biopharmaceutical Company focused on developing and commercializing orally...
Mount Tam Biotechnologies Announces that the European Patent Office Has Allowed a Key Patent for Lead Compound TAM-01
February 22, 2018 09:00 ET | Mount Tam Biotechnologies Inc.
NOVATO, CA , Feb. 22, 2018 (GLOBE NEWSWIRE) -- Mount Tam Biotechnologies, Inc. ("Mount Tam") (OTC PINK: MNTM), a company focused on the discovery and development of novel mTOR inhibitors, is pleased...
Hemispherx Biopharma Receives the European Patent Office Grant of New Composition of Matter Patent Covering Ampligen(R) Formulations
September 28, 2015 08:30 ET | AIM ImmunoTech Inc.
PHILADELPHIA, Sept. 28, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced that it received formal notice on September 21, 2015, that the...